Clinical Trial

Neuroimaging of Parkinson's

Recruiting
View on ClinicalTrials.gov →
Summary
Parkinson's Disease (PD) is a neurodegenerative disorder caused by dysfunction in both subcortical structures and the cortex. The investigators recently discovered a new brain system called the Somato-Cognitive Action Network (SCAN), which could be a primary locus of dysfunction in PD. Here, the investigators will use magnetic resonance imaging techniques in PD patients to test whether SCAN is critical for PD. The investigators will determine whether SCAN is connected to PD-relevant subcortical structures, and whether PD patients exhibit altered subcortical-to-SCAN connectivity. If successful, this work will identify SCAN as a specific circuit altered in PD patients that can serve as a new target for future neuromodulatory PD therapies.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-06-09; most recent amendment 2026-04-07.
Status change: Not Yet Recruiting → Recruiting 2025-10-09
Trial Details
NCT Number NCT07024875
Lead Sponsor Washington University School of Medicine
Collaborators: National Institute of Neurological Disorders and Stroke (NINDS), Michael J. Fox Foundation for Parkinson's Research
Conditions Parkinsons Disease (PD)
Enrollment 120 participants
Start Date 2025-08-01
Primary Completion 2031-01 (estimated)
Study Completion 2031-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-13